Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York.
Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York.
JACC Cardiovasc Interv. 2014 Apr;7(4):345-53. doi: 10.1016/j.jcin.2013.12.196. Epub 2014 Mar 13.
Rotational atherectomy facilitates percutaneous coronary intervention for complex de novo lesions with severe calcification. A strategy of routine rotational atherectomy has not, however, conferred reduction in restenosis or major adverse cardiac events. As it is technically demanding, rotational atherectomy is also uncommon. At this 25-year anniversary since the introduction of rotational atherectomy, we sought to review the current state-of-the-art in rotational atherectomy technique, safety, and efficacy data in the modern era of drug-eluting stents, strategies to prevent and manage complications, including slow-flow/no-reflow and burr entrapment, and appropriate use in the context of the broader evolution in the management of stable ischemic heart disease. Fundamental elements of optimal technique include use of a single burr with burr-to-artery ratio of 0.5 to 0.6-rotational speed of 140,000 to 150,000 rpm, gradual burr advancement using a pecking motion, short ablation runs of 15 to 20 s, and avoidance of decelerations >5,000 rpm. Combined with meticulous technique, optimal antiplatelet therapy, vasodilators, flush solution, and provisional use of atropine, temporary pacing, vasopressors, and mechanical support may prevent slow-flow/no-reflow, which in contemporary series is reported in 0.0% to 2.6% of cases. On the basis of the results of recent large clinical trials, a subset of patients with complex coronary artery disease previously assigned to rotational atherectomy may be directed instead to medical therapy alone or bypass surgery. For patients with de novo severely calcified lesions for which rotational atherectomy remains appropriate, referral centers of excellence are required.
旋磨术有助于经皮冠状动脉介入治疗复杂的严重钙化的初发型病变。然而,常规旋磨术策略并未降低再狭窄或主要不良心脏事件的发生率。由于其技术要求较高,旋磨术也不常见。在旋磨术问世 25 周年之际,我们旨在回顾旋磨术技术、安全性和当代时代药物洗脱支架的有效性数据的最新进展,预防和处理并发症的策略,包括慢血流/无复流和磨头嵌顿,以及在稳定型缺血性心脏病管理的广泛演变背景下的合理应用。最佳技术的基本要素包括使用单个磨头,磨头与动脉比为 0.5 至 0.6-旋转速度为 140,000 至 150,000 rpm,使用啄击动作逐渐推进磨头,短消融时间为 15 至 20 秒,避免减速 >5,000 rpm。结合细致的技术、最佳的抗血小板治疗、血管扩张剂、冲洗溶液以及临时使用阿托品、临时起搏、血管加压素和机械支持,可以预防慢血流/无复流,在当代系列中,报道的发生率为 0.0%至 2.6%。基于最近大型临床试验的结果,一部分先前被分配接受旋磨术的复杂冠状动脉疾病患者可能会被单独转为药物治疗或旁路手术。对于仍适合旋磨术的初发型严重钙化病变患者,需要转诊到卓越中心。